Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The evolution of new agents for ovulation induction

M J Gast1

  • 1Department of Obstetrics and Gynecology, University of Pennsylvania, USA.

Seminars in Reproductive Endocrinology
|November 1, 1996
PubMed
Summary

Clinical ovulation induction therapy is evolving with new molecular and cellular biology insights. Future treatments may involve recombinant gonadotropins and genetic advancements for improved fertility outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.

Neurology·2007
Same author

A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.

American journal of obstetrics and gynecology·1999
Same author

Regulation of creatine kinase isoenzymes in human placenta during early, mid-, and late gestation.

Journal of the Society for Gynecologic Investigation·1996
Same author

Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone.

Fertility and sterility·1996
Same author

Future of the hamster oocyte penetration assay?

Fertility and sterility·1995
Same author

Does intrauterine insemination offer an advantage to cervical cap insemination in a donor insemination program?

Fertility and sterility·1995

Area of Science:

  • Reproductive Endocrinology
  • Molecular Biology
  • Biochemistry

Background:

  • Clinical ovulation induction therapy has seen limited advancement for over three decades.
  • Progress is anticipated from enhanced understanding of ovulation biology, molecular/cellular biology, and steroid/gonadotropin biochemistry.

Purpose of the Study:

  • To discuss emerging opportunities in the clinical and basic science of ovulation induction.
  • To highlight how new technologies can drive future research and therapeutic development.

Main Methods:

  • Review of current and emerging scientific literature.
  • Discussion of advancements in molecular and cellular biology.
  • Exploration of new technologies like the Human Genome Project and genetic manipulation in animal models.

Main Results:

  • Recombinant gonadotropins and analogues show promise for near-future therapies.
  • Central mechanisms for reproductive axis modulation offer potential benefits.
  • Improved understanding of folliculogenesis, oocyte maturation, and implantation is expected.

Conclusions:

  • Significant opportunities exist for innovation in ovulation induction therapies.
  • Genetic technologies and a deeper biological understanding will likely revolutionize fertility treatments.
  • Future research directions include dissecting disordered ovulation mechanisms and enhancing implantation success in assisted reproductive technologies (ART).

Related Experiment Videos